<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0256-9574</journal-id>
<journal-title><![CDATA[SAMJ: South African Medical Journal]]></journal-title>
<abbrev-journal-title><![CDATA[SAMJ, S. Afr. med. j.]]></abbrev-journal-title>
<issn>0256-9574</issn>
<publisher>
<publisher-name><![CDATA[Health and Medical Publishing Group]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0256-95742012000800017</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Loeys-Dietz syndrome: a possible solution for Akhenaten's and his family's mystery syndrome]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Eshraghian]]></surname>
<given-names><![CDATA[Ahad]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Loeys]]></surname>
<given-names><![CDATA[Bart]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Shiraz University of Medical Science Department of Internal Medicine ]]></institution>
<addr-line><![CDATA[Shiraz ]]></addr-line>
<country>Iran</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Antwerp University Hospital Center for Medical Genetics ]]></institution>
<addr-line><![CDATA[Antwerp ]]></addr-line>
<country>Belgium</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2012</year>
</pub-date>
<volume>102</volume>
<numero>8</numero>
<fpage>661</fpage>
<lpage>664</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.za/scielo.php?script=sci_arttext&amp;pid=S0256-95742012000800017&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.org.za/scielo.php?script=sci_abstract&amp;pid=S0256-95742012000800017&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://www.scielo.org.za/scielo.php?script=sci_pdf&amp;pid=S0256-95742012000800017&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[The presence of a familial disease among royal members of 18th dynasty of the new kingdom who ruled in Egypt from the mid-16th to the early 11th centuries BC has been established, largely prompted by the bizarre body shape of Akhenaten (the iconoclastic pharaoh of this dynasty) and his family, as demonstrated in statues and artwork. It had been thought previously that this was an expression of a revolutionised artistic style that followed radical reforms by Akhenaten of Egyptian society, but recent studies on mummies confirmed the presence of a constellation of corresponding pathologies. Several illnesses have been suggested to solve this enigma; we propose Loeys-Dietz syndrome as a probable diagnosis for this genetic affliction within the royal family.]]></p></abstract>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>FORUM    <br>   HISTORY OF MEDICINE</b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b><a name="top"></a>Loeys-Dietz    syndrome: a possible solution for Akhenaten's and his family's mystery syndrome</b></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Ahad Eshraghian;    Bart Loeys</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> Department of    Internal Medicine, Shiraz University of Medical Science, Shiraz, Iran. Bart    Loeys is from the Center for Medical Genetics, Antwerp University Hospital,    Antwerp, Belgium</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back">Correspondence    to</a></font> </p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p> <hr size="1" noshade>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The presence of    a familial disease among royal members of 18th dynasty of the new kingdom who    ruled in Egypt from the mid-16th to the early 11th centuries BC has been established,    largely prompted by the bizarre body shape of Akhenaten (the iconoclastic pharaoh    of this dynasty) and his family, as demonstrated in statues and artwork. It    had been thought previously that this was an expression of a revolutionised    artistic style that followed radical reforms by Akhenaten of Egyptian society,    but recent studies on mummies confirmed the presence of a constellation of corresponding    pathologies. Several illnesses have been suggested to solve this enigma; we    propose Loeys-Dietz syndrome as a probable diagnosis for this genetic affliction    within the royal family.</font></p> <hr size="1" noshade>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The history of    ancient Egypt holds many unsolved, fascinating mysteries. The 18th dynasty is    the most famous and glorious of ancient Egyptian dynasties that ruled in Egypt    form the mid-16th to the early 11th centuries BC. Many well-known pharaohs such    as Hatshepsut, Thutmose III and Tutankhamun belong to this dynasty. Ancient    Egypt had large territories and experienced a magnificent period of economic    and social development. One little-known aspect of this dynasty that has been    the subject of debate is the presence of a familial disease, a notion originating    from several statues, sculptures and reliefs of Akhenaten and his family that    show elongated heads, faces and extremities, and an underdeveloped thorax with    gynaecomastia (<a href="#f1">Fig. 1</a>). Tutankhamun's death at a young age    tends to support this theory, as this might have been indicative of a genetic    disorder, especially because royal family marriages between brothers and sisters    were frequent, to preserve the royal bloodline, which increased the risk of    inherited disorders (<a href="#f2">Fig. 2</a>).</font></p>     <p><a name="f1"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/samj/v102n8/17f01.jpg"></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><a name="f2"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/samj/v102n8/17f02.jpg"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Several hypotheses    have been proposed to explain a familial disease that caused the bizarre appearance    of the royalty, including Marfan syndrome, Wilson-Turner X-linked mental retardation    syndrome, Fr&ouml;hlich syndrome (adiposogenital dystrophy), Klinefelter syndrome,    androgen insensitivity syndrome,<sup>1</sup> myotonic dystrophy,<sup>2</sup>    and aromatase excess syndrome in conjunction with sagittal craniosynostosis    syndrome, or Antley-Bixler syndrome.<sup>3</sup> Hawass and co-workers published    results of their molecular genetic studies on mummified remains of the royal    family of the 18th dynasty to determine any pathologies and familial disease    that might have afflicted them.<sup>4</sup> Tests showed no sign of craniosynostoses    and Antley-Bixler or Marfan syndrome, and could find no evidence of gynaecomastia    because the anterior chest wall of the mummies was not available. Therefore,    the presence or absence of gynaecomastia is not clear. The feminised appearance    of Akhenaten was excluded by the pelvic bone shape. The study group also found    evidence of <i>Plasmodium falciparum</i> infection in the mummies. They concluded    that none of the presumed hypotheses about the familial disease was correct,    but found a constellation of deformities in Tutankhamun and his family. They    did not propose any specific diagnoses or syndromes that could explain repeated    deformities and pathologies in the members of royal family.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">We hypothesise    that the 18th dynasty royal family of the new Egyptian kingdom might have suffered    from Loeys-Dietz syndrome, which might solve the medical mystery of the 18th    dynasty. We emphasise that previous theories regarding the royal family familial    illness mainly originated from reliefs, sculptures and limited medical facts    obtained from limited studies. Our postulation is based on pathological findings    in a recent study on mummies.<sup>4</sup></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Discussion</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Loeys-Dietz syndrome    (LDS) is an autosomal dominant inherited disorder of connective tissue that    has been recently introduced as an important cause of familial aortic aneurysm.    LDS is caused by heterozygous mutations in genes encoding transforming growth    factor &acirc; receptors 1 and 2 <i>(TGFBR1</i> and TGFBR2).<sup>5</sup> Patients    affected with this syndrome are characterised by specific clinical features    involving the vascular and skeletal systems as well as craniofacial morphology    and skin appearance.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">LDS type 1 accounts    for nearly 75% of patients with specific craniofacial dysmorpology. In patients    with LDS type 2, skin abnormalities are prominent features, and they do not    have major craniofacial involvement. Diagnosis is confirmed by detection of    mutations in <i>TGFBR1</i> and <i>TGFBR2.<sup>6</sup></i></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">LDS is characterised    by 4 major categories of clinical features:</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>1.</b>&nbsp;<b>Cardiovascular    system.</b> The most important finding in LDS patients is dilatation of the    aorta at the level of the Valsalva sinuses, while aneurysm of the ascending    or descending aorta is seen less frequently.<sup>6</sup> Congenital heart diseases    such as atrial septal defect (ASD), bicuspid aortic valve and patent ductus    arteriosus (PDA) are also more prevalent in LDS patients.<sup>7</sup> Mitral    valve prolapse and regurgitation along with cardiomyopathy secondary to coronary    artery dysplasia have been reported in these patients.<sup>8</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>2.</b>&nbsp;<b>Skeletal    findings.</b> Joint hyperlaxity, arachnodactyly, pecus excavatum or carinatum,    scoliosis and contractures of the feet (talipes equinovarus) are seen in LDS    patients, and are also common in Marfan syndrome. Pes planus, spine instability    and spondylolisthesis are recurrent findings in this syndrome.<sup>6</sup> Dolichostenomelia    (long limbs, leading to an increase in the arm span-to-height ratio and a decrease    in the upper-to-lower segment ratio) is less common in this syndrome.<sup>9</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>3.</b>&nbsp;<b>Facial    dysmorphology.</b> Abnormal facial features are prominent in type II LDS patients.    Hypertelorism (wide-set eyes) and a cleft palate or a bifid uvula are characteristic    of LDS. Craniosynostosis in the forms of dolichocephaly, bracycephaly and trigonocephaly    is common.<sup>6</sup> Other craniofacial features are retrognathia, blue sclerae,    highly arched palate and dental crowding.<sup>10</sup> In type II LDS patients,    facial findings are not so severe and include a tall, broad forehead; frontal    bossing; a high anterior hair line; hypoplastic supraorbital margins; and a    myopathic face.<sup>11</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>4.</b>&nbsp;<b>Skin    findings.</b> These patients have velvety and translucent skin with easy bruising    and delayed wound healing. Skin manifestations without striking facial abnormalities    are seen in type II LDS.<sup>6</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Akhenaten: The    apostate</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Amenhotep IV, the    strangest ruler of ancient Egypt, was the son of Amenhotep III and his queen    Tiye. Some Egyptologists have considered him a criminally mad ruler, while others    have admired him as a great reformist. His radical and extensive reform of Egyptian    society influenced religion, art, politics and other aspects of Egyptian life.    He is probably the first and the only pharaoh who practised monotheism and tried    to propagate this doctrine in and around the Egyptian territories. He changed    his name to Akhenaten (he who serves Aten) and began to replace images of Amon    (the great Egyptian god) and other statues of gods and goddesses with his single    god named Aten, whose image was a sun disk. When conflict increased, he left    Thebes (the ancient capital of Egypt) and moved to a new region in Middle Egypt,    near Amarna village in modern Egypt, and built a new capital named Akhet-Aten    (Horizons of the sun disk). He forbade depicting any other god or goddess, and    destroyed or seized their temples, which led to a religious war within the country.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Amarna artistic    style</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Sculptors in ancient    Egypt showed kings and royalty in an idealised fashion, and did not show physical    defects. But in the new art style that was a consequence of Akhenaten's reforms,    artists were free to depict reality, such as an unattractive body, and even    exaggerate these features (as cartoonists tend to do).<sup>12</sup> Therefore,    it is possible that Akhenaten really had an elongated face, underdeveloped thorax    with gynaecomastia and a prominent abdomen, and current statues and sculptures    are exaggerated forms of this unusual appearance.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Is Akhenaten's    religion a key to his disease?</b></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Aten was the name    of Akhenaten's god that was reflected as a sun disk. The sun was the symbol    of Aten, whose temples had no roof so that sunshine could play directly onto    the altar. Akhenaten spent all of his reign propagating Aten throughout Egypt.    In a society with traditional and religious prejudices and a long history of    numerous deities, what made him introduce one supreme god and eliminate all    others? Some have argued that Aten was a political strategy to confine the power    of Amon (King of the gods) and his priests. However, as reflected in papyruses,    Akhenaten truly adored his god and spent much of his daily routine worshipping    Aten, naked, in sunlight, to receive his bliss (<a href="#f3">Fig. 3</a>). One    might also think that Akhenaten had an illness that was alleviated by exposure    to sunshine.</font></p>     <p>&nbsp;</p>     <p><a name="f3"></a></p>     <p align="center"><img src="/img/revistas/samj/v102n8/17f03.jpg"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Can Loeys-Dietz    syndrome justify the pathologies in Akhenaten and his family?</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Different syndromes    and diseases have been hypothesised to explain a probable underlying disease    in Akhenaten, Tutankhamun and 18th dynasty royalty. Marfan syndrome was suspected    owing to the marfanoid features of Akhenaten and his family in statues. Recently,    however, Marfan syndrome and similar diseases were excluded as none of the royalty    fulfilled Marfan criteria.<sup>4</sup> However, the latter study confirmed the    presence of a group of pathologies in royal members of the 18th dynasty.<sup>4</sup>    LDS is a clinical continuum and should be suspected in patients with Marfan-like    features not fulfilling Ghent criteria.<sup>13</sup></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Hawass <i>et al.</i>    found repeatedly in the royal family, not only clinical features of LDS, but    also scoliosis, club foot, incisional hernia, cleft palate, retrognathism, dental    crowding and highly arched palate.<sup>4</sup> No mummy showed dolichostenomalia,    whilst in LDS, in contrast to Marfan syndrome, dolichostenomalia is not frequent.    According to their findings, Akhenaten and Tutankhamun had brachycephaly, which    can occur in LDS patients (<a href="/img/revistas/samj/v102n8/17t01.jpg">Table 1</a>).</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Cardiac pathologies    in LDS, such as ASD and cardiomyopathy, are prevalent, and both can induce pulmonary    hypertension and right-sided heart failure.<sup>14</sup> Patients with right-sided    heart failure will develop liver congestion that can progress to cirrhosis over    time. Patients with right-sided heart failure even without cirrhosis may have    ascites, gynaecomastia and peripheral oedema. Therefore the unusual shape of    Akhenaten in statues and paintings of a prominent abdomen and large breasts    could be due to ascites and gynaecomastia, which are seen in cirrhosis secondary    to right-sided heart failure in the context of LDS; this can be a reason for    gynaecomastia if proved to be present.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Vitamin D deficiency    has been described in patients with LDS.<sup>15</sup> Diffuse musculoskeletal    pain and even myopathy, chronic fatigue and depression can occur in patients    with hypovitaminosis D.<sup>16</sup> Exposure to sunlight is the main source    of vitamin D, and treatment of vitamin D deficiency with sun exposure has been    reported.<sup>17</sup></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>TGFBR</i> gene    polymorphism is associated with bone mineral density and bone turnover, and    osteopenia/osteoporosis may also occur in LDS.<sup>18</sup> Furthermore, patients    with LDS suffer from some skin manifestations as described above. TGF-&acirc;    signalling pathway in the cells is initiated by binding of the ligand to the    TGFBR 2 and subsequent phosphorylation of TGFBR 1. Activated TGFBR 1/TGFBR 2    complex mediates transcription of multiple genes via its downstream Smad signalling    proteins. Mutations in TGFBR 1/ TGFBR 2 as seen in LDS enhance the TGF-&acirc;    signalling pathway and increase transcription of multiple downstream genes and    proteins.<sup>5</sup> Quan <i>et al.</i> showed that solar ultraviolet irradiation    reduces collagen in human skin which is mediated by blocking TGFBRII/Smad signalling.<sup>19</sup>    This finding was also confirmed in other studies.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The foregoing findings    may provide reasons to justify the association between Akhenaten's disease and    his religious reforms. Akhenaten might have suffered from chronic musculoskeletal    pain owing to vitamin D deficiency and osteoporosis secondary to LDS, and sunshine    exposure might have relieved his pain. Furthermore, the diseased TGF-&acirc;    signalling pathway was down-regulated by his sunshine worshipping of Aten. In    this way, he indeed received physical and spiritual beneficence from his god,    which strengthened his faith in Aten despite considerable political, religious    and social pressures.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Both types of LDS    are generally believed to be two sides of a clinical spectrum. Therefore, an    affected individual could have no striking facial appearance. Developmental    delay has been reported to occur in a small minority of patients with LDS, but    most have normal intellectual ability. Only 25% of these patients have an affected    parent, and 75% of patients developed <i>de novo</i> mutations. So it would    not be unusual if Akhenaten, with the more severe form of the syndrome, had    apparently normal parents or children. Another possibility is that Tutankhamun    was more severely affected than his father Akhenaten, which may be explained    by homozygocity for the TGFBR mutation, because of the consanguinity.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The main cause    of early mortality (mean age 26.1 years) in LDS is dissection of a dilated aorta.    Although confirmation of aortic aneurysm in the remaining mummies is not possible,    neither Akhenaten and Tutankhamun nor other relatives were more than 50 years    old, as determined by DNA studies.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Lastly: a related    syndrome with aortic aneurysm and early-onset osteoarthritis was recently found    to be caused by mutations in the <i>SMAD3</i> gene. This gene encodes some proteins    that are involved in the TGFB pathway. Patients with this condition also presented    with bifid uvula/cleft palate, hypertelorism and skin abnormalities.<sup>20</sup></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Conclusion</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Based on the foregoing    findings, the possibility of Loeys-Dietz syndrome or an abnormality in the SMAD3    gene should be considered as the underlying disease of this Egyptian royal family.    Mutations in <i>TGFBR1</i> and <i>TGFBR2</i> or <i>SMAD3</i> from DNA of remaining    mummies can clarify one of the mysteries of Egyptian history.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>References</b></font></p>     ]]></body>
<body><![CDATA[<!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1.&nbsp;Walshe    JM. Tutankhamun: Klinefelter's or Wilsons? Lancet 1973;1(7794):109-110.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548970&pid=S0256-9574201200080001700001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2.&nbsp;Cattaino    G, Vicario L. Myotonic dystrophy in Ancient Egypt. Eur Neurol 1999;41(2):59-63.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548971&pid=S0256-9574201200080001700002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3.&nbsp;Braverman    IM, Redford DB, Mackowiak PA. Akhenaten and the strange physiques of Egypt's    18th dynasty. Ann Intern Med 2009;150(8):556-560.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548972&pid=S0256-9574201200080001700003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4.&nbsp;Hawass    Z, Gad YZ, Ismail S, et al. Ancestry and pathology in King Tutankhamuns family.    JAMA 2010;303(7):638-647.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548973&pid=S0256-9574201200080001700004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5.&nbsp;Van Hemelrijk    C, Renard M, Loeys B. The Loeys-Dietz syndrome: an update for the clinician.    Curr Opin Cardiol 2010; 25(6):546-551.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548974&pid=S0256-9574201200080001700005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6.&nbsp;Loeys BL,    Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta    receptor. N Engl J Med 2006;355(8):788-798.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548975&pid=S0256-9574201200080001700006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7.&nbsp;Attias    D, Stheneur C, Roy C, et al. Comparison of clinical presentations and outcomes    between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related    disorders. Circulation 2009;120:2541-2549.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548976&pid=S0256-9574201200080001700007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8.&nbsp;Eckman    PM, Hsich E, Rodriguez ER, Gonzalez-Stawinski GV, Moran R, Taylor DO. Impaired    systolic function in Loeys-Dietz syndrome: a novel cardiomyopathy? Circ Heart    Fail 2009;2:707-708.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548977&pid=S0256-9574201200080001700008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Jamsheer A,    Henggeler C, Wierzba J, et al. A new sporadic case of early-onset Loeys-Dietz    syndrome due to the recurrent mutation p.R528C in the TGFBR2 gene substantiates    interindividual clinical variability. J Appl Genet 2009;50:405-410.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548978&pid=S0256-9574201200080001700009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10.&nbsp;Yetman    AT, Beroukhim RS, Ivy DD, Manchester D. Importance of the clinical recognition    of Loeys-Dietz syndrome in the neonatal period. Pediatrics 2007;119:e1199-e1202.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548979&pid=S0256-9574201200080001700010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11.&nbsp;Ades LC.    Evolution of the face in Loeys-Dietz syndrome type II: longitudinal observations    from infancy in seven cases. Clin Dysmorphol 2008;17:243-248.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548980&pid=S0256-9574201200080001700011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12.&nbsp;Huppertz    A, Wildung D, Kemp BJ, et al Nondestructive insights into composition of the    sculpture of Egyptian Queen Nefertiti with CT. Radiology 2009;251(1):233-240.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548981&pid=S0256-9574201200080001700012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13.&nbsp;Mizuguchi    T, Collod-Beroud G, Akiyama T, et al. Heterozygous TGFBR2 mutations in Marfan    syndrome. Nat Genet 2004;36:855-860.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548982&pid=S0256-9574201200080001700013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14.&nbsp;Vogel    M, Berger F, Kramer A, Alexi-Meshkishvili V, Lange PE. Incidence of secondary    pulmonary hypertension in adults with atrial septal or sinus venosus defects.    Heart 1999;82:30.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548983&pid=S0256-9574201200080001700014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15.&nbsp;Kirmani    S, Tebben PJ, Lteif AN, et al. Germline TGF-beta receptor mutations and skeletal    fragility: a report on two patients with Loeys-Dietz syndrome. Am J Med Genet    A 2010;152A(4):1016-1019.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548984&pid=S0256-9574201200080001700015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16.&nbsp;Fabbriciani    G, Pirro M, Leli C, et al Diffuse muscoskeletal pain and proximal myopathy:    do not forget hypovitaminosis D. J Clin Rheumatol 2010;16(1):34-37.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548985&pid=S0256-9574201200080001700016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17.&nbsp;Chandra    P, Agarwal M, Sharma SG, Basra S. Tanning can be an alternative source of vitamin    d in high risk populations. J Nutr Sci Vitaminol (Tokyo) 2008;54(1):105.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548986&pid=S0256-9574201200080001700017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18.&nbsp;Lau HH,    Ho AY, Luk KD, Kung AW. Transforming growth factor-beta1 gene polymorphisms    and bone turnover, bone mineral density and fracture risk in southern Chinese    women. Calcif Tissue Int 2004;74(6):516-521.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548987&pid=S0256-9574201200080001700018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">19.&nbsp;Quan T,    He T, Kang S, Voorhees JJ, Fisher GJ. Solar ultraviolet irradiation reduces    collagen in photoaged human skin by blocking transforming growth factor-beta    type II receptor/Smad signaling. Am J Pathol 2004;165(3):741-751.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548988&pid=S0256-9574201200080001700019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">20.&nbsp;Van de    Laar IM, Oldenburg RA, Pals G, et al. Mutations in SMAD3 cause a syndromic form    of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Gene    2011:43,121-126.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=548989&pid=S0256-9574201200080001700020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><a name="back"></a><a href="#top"><img src="/img/revistas/samj/v102n8/seta.jpg" border="0"></a>    Correspondence to:    <br>   </b> A Eshraghian    <br>   (<a href="mailto:eshraghiana@yahoo.com">eshraghiana@yahoo.com</a>)</font></p>      ]]></body>
<REFERENCES></REFERENCES<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walshe]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tutankhamun: Klinefelter's or Wilsons?]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1973</year>
<volume>1</volume>
<numero>7794</numero>
<issue>7794</issue>
<page-range>109-110</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cattaino]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Vicario]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Myotonic dystrophy in Ancient Egypt]]></article-title>
<source><![CDATA[Eur Neurol]]></source>
<year>1999</year>
<volume>41</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>59-63</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Braverman]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
<name>
<surname><![CDATA[Redford]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
<name>
<surname><![CDATA[Mackowiak]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Akhenaten and the strange physiques of Egypt's 18th dynasty]]></article-title>
<source><![CDATA[Ann Intern Med]]></source>
<year>2009</year>
<volume>150</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>556-560</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hawass]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Gad]]></surname>
<given-names><![CDATA[YZ]]></given-names>
</name>
<name>
<surname><![CDATA[Ismail]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Ancestry and pathology in King Tutankhamuns family]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2010</year>
<volume>303</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>638-647</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Hemelrijk]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Renard]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Loeys]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The Loeys-Dietz syndrome: an update for the clinician]]></article-title>
<source><![CDATA[Curr Opin Cardiol]]></source>
<year>2010</year>
<volume>25</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>546-551</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Loeys]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Schwarze]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Holm]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Aneurysm syndromes caused by mutations in the TGF-beta receptor]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2006</year>
<volume>355</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>788-798</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Attias]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Stheneur]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Roy]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2009</year>
<volume>120</volume>
<page-range>2541-2549</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eckman]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Hsich]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez-Stawinski]]></surname>
<given-names><![CDATA[GV]]></given-names>
</name>
<name>
<surname><![CDATA[Moran]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[DO]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Impaired systolic function in Loeys-Dietz syndrome: a novel cardiomyopathy?]]></article-title>
<source><![CDATA[Circ Heart Fail]]></source>
<year>2009</year>
<volume>2</volume>
<page-range>707-708</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jamsheer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Henggeler]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wierzba]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A new sporadic case of early-onset Loeys-Dietz syndrome due to the recurrent mutation p: R528C in the TGFBR2 gene substantiates interindividual clinical variability]]></article-title>
<source><![CDATA[J Appl Genet]]></source>
<year>2009</year>
<volume>50</volume>
<page-range>405-410</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yetman]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Beroukhim]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Ivy]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Manchester]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Importance of the clinical recognition of Loeys-Dietz syndrome in the neonatal period]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2007</year>
<volume>119</volume>
<page-range>e1199-e1202</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ades]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Evolution of the face in Loeys-Dietz syndrome type II: longitudinal observations from infancy in seven cases]]></article-title>
<source><![CDATA[Clin Dysmorphol]]></source>
<year>2008</year>
<volume>17</volume>
<page-range>243-248</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huppertz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wildung]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kemp]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Nondestructive insights into composition of the sculpture of Egyptian Queen Nefertiti with CT]]></article-title>
<source><![CDATA[Radiology]]></source>
<year>2009</year>
<volume>251</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>233-240</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mizuguchi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Collod-Beroud]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Akiyama]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Heterozygous TGFBR2 mutations in Marfan syndrome]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2004</year>
<volume>36</volume>
<page-range>855-860</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vogel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Kramer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alexi-Meshkishvili]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Lange]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects]]></article-title>
<source><![CDATA[Heart]]></source>
<year>1999</year>
<volume>82</volume>
<page-range>30</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirmani]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tebben]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lteif]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Germline TGF-beta receptor mutations and skeletal fragility: a report on two patients with Loeys-Dietz syndrome]]></article-title>
<source><![CDATA[Am J Med Genet A]]></source>
<year>2010</year>
<volume>152A</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1016-1019</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fabbriciani]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pirro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Leli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Diffuse muscoskeletal pain and proximal myopathy: do not forget hypovitaminosis D]]></article-title>
<source><![CDATA[J Clin Rheumatol]]></source>
<year>2010</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>34-37</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chandra]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Agarwal]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[Basra]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tanning can be an alternative source of vitamin d in high risk populations]]></article-title>
<source><![CDATA[J Nutr Sci Vitaminol]]></source>
<year>2008</year>
<volume>54</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>105</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lau]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[AY]]></given-names>
</name>
<name>
<surname><![CDATA[Luk]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
<name>
<surname><![CDATA[Kung]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Transforming growth factor-beta1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women]]></article-title>
<source><![CDATA[Calcif Tissue Int]]></source>
<year>2004</year>
<volume>74</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>516-521</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quan]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[He]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Voorhees]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling]]></article-title>
<source><![CDATA[Am J Pathol]]></source>
<year>2004</year>
<volume>165</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>741-751</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van de Laar]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
<name>
<surname><![CDATA[Oldenburg]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Pals]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis]]></article-title>
<source><![CDATA[Nat Gene]]></source>
<year>2011</year>
<page-range>43,121-126</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
